To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene FOXA1TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
287 supporting clones for gene FOXA1 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
BE672842 Prostate .a 1 to 392 392 to 1   tiling clone,   392/392
(100 %)
1 diff
(99.8 %id)
BU860564 adenocarcinoma, cell line, breast .a 132 to 653 1 to 520       520/980
(53 %)
32 diff
(96.8 %id)
NM_004496.2   .a 132 to 3239 1 to 3108 exact RefSeq, AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 3108/3108
(100 %)
0 diff
(100 %id)
DA705947   .a 297 to 849 2 to 556   capped   555/555
(100 %)
4 diff
(99.3 %id)
DA340997 substantia nigra .a 299 to 799 2 to 502   capped   501/501
(100 %)
2 diff
(99.7 %id)
AK313785 trachea .a 305 to 1862 1 to 1558 exact     1558/1558
(100 %)
2 diff
(99.9 %id)
DB196023 trachea .a 306 to 802 2 to 498   capped   497/497
(100 %)
0 diff
(100 %id)
DB206171 trachea .a 306 to 887 2 to 583   capped   582/582
(100 %)
1 diff
(99.9 %id)
DB206453 trachea .a 306 to 883 2 to 579   capped   578/578
(100 %)
1 diff
(99.9 %id)
DN995790 breast cancer, Mammary gland (cancer tissue) .a 308 to 993 1 to 687       687/687
(100 %)
9 diff
(98.7 %id)
DA455396 tongue, tumor tissue .a 321 to 637 2 to 318   capped   317/317
(100 %)
1 diff
(99.7 %id)
DA455401 tongue, tumor tissue .a 321 to 869 2 to 550   capped   549/549
(100 %)
2 diff
(99.7 %id)
BI464245 testis .a 381 to 1096 1 to 726       726/726
(100 %)
21 diff
(97.2 %id)
BC033890 testis .a 382 to 3239 1 to 2858 exact tiling clone, available from MGC, AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 2858/2858
(100 %)
3 diff
(99.9 %id)
U39840 lung .a 382 to 3243 26 to 2870 G72A N125M G126N L127G G128L ... tiling clone,   2845/2872
(99 %)
44 diff
(98.5 %id)
DA450485 tongue, tumor tissue .a 394 to 914 2 to 523   capped   522/522
(100 %)
6 diff
(98.9 %id)
DA459302 tongue, tumor tissue .a 396 to 963 2 to 572   capped   571/571
(100 %)
5 diff
(99.2 %id)
DA444682 tongue, tumor tissue .a 421 to 1009 2 to 588   capped   587/587
(100 %)
2 diff
(99.7 %id)
DA435491 tongue, tumor tissue .a 422 to 979 2 to 560   capped   559/559
(100 %)
2 diff
(99.7 %id)
CV024601 mixed .a 444 to 1100 1 to 656       656/658
(99 %)
3 diff
(99.6 %id)
TI_1948131934   .a 444 to 1131 129 to 815       687/1339
(51 %)
26 diff
(98.1 %id)
TI_1948131935   .a 444 to 1120 138 to 819       682/1179
(57 %)
18 diff
(98.5 %id)
TI_1948132271   .a 444 to 1130 124 to 812       689/1345
(51 %)
44 diff
(96.8 %id)
TI_1948132570   .a 444 to 1072 128 to 765       638/1471
(43 %)
25 diff
(98.4 %id)
TI_1948132571   .a 444 to 1101 137 to 799       663/1127
(58 %)
23 diff
(98.0 %id)
TI_1948132881   .a 444 to 1252 130 to 933       804/1266
(63 %)
40 diff
(96.9 %id)
TI_1948132882   .a 444 to 1169 139 to 873       735/1114
(65 %)
25 diff
(97.8 %id)
BQ956504 sciatic nerve .a 1656 to 2506 24 to 880       857/923
(92 %)
27 diff
(97.1 %id)
AW948974 prostate_tumor .a 1673 to 2085 416 to 3     Submitted on the opposite strand 414/416
(99 %)
0 diff
(100 %id)
BE771528 prostate_tumor .a 1702 to 2112 10 to 420       411/424
(96 %)
5 diff
(98.9 %id)
BE771538 prostate_tumor .a 1702 to 2112 18 to 428       411/432
(95 %)
7 diff
(98.4 %id)
BE771515 prostate_tumor .a 1703 to 2112 15 to 424       410/428
(95 %)
6 diff
(98.6 %id)
BE771516 prostate_tumor .a 1703 to 2112 21 to 430       410/434
(94 %)
6 diff
(98.7 %id)
BE771517 prostate_tumor .a 1703 to 2112 16 to 424       409/428
(95 %)
8 diff
(98.2 %id)
BE771518 prostate_tumor .a 1703 to 2112 20 to 429       410/433
(94 %)
6 diff
(98.7 %id)
BE771519 prostate_tumor .a 1703 to 2086 379 to 1       379/388
(97 %)
6 diff
(98.5 %id)
BE771521 prostate_tumor .a 1703 to 2112 26 to 433       408/437
(93 %)
10 diff
(97.8 %id)
BE771523 prostate_tumor .a 1703 to 2112 20 to 429       410/433
(94 %)
6 diff
(98.7 %id)
BE771524 prostate_tumor .a 1703 to 2112 15 to 425       411/429
(95 %)
8 diff
(98.2 %id)
BE771529 prostate_tumor .a 1703 to 2112 411 to 4       408/420
(97 %)
0 diff
(100 %id)
BE771531 prostate_tumor .a 1703 to 2112 29 to 438       410/442
(92 %)
6 diff
(98.7 %id)
BE771532 prostate_tumor .a 1703 to 2112 13 to 422       410/426
(96 %)
7 diff
(98.4 %id)
BE771533 prostate_tumor .a 1703 to 2103 405 to 5       401/414
(96 %)
0 diff
(100 %id)
BE771534 prostate_tumor .a 1703 to 2103 400 to 2       399/409
(97 %)
0 diff
(100 %id)
BE771535 prostate_tumor .a 1703 to 2112 16 to 425       410/429
(95 %)
5 diff
(98.9 %id)
BE771537 prostate_tumor .a 1703 to 2102 20 to 419       400/419
(95 %)
9 diff
(97.9 %id)
BE771539 prostate_tumor .a 1703 to 2112 17 to 426       410/430
(95 %)
6 diff
(98.7 %id)
BE771542 prostate_tumor .a 1703 to 2103 407 to 9       399/416
(95 %)
0 diff
(100 %id)
BE837319 prostate_normal .a 1706 to 2112 1 to 407       407/411
(99 %)
9 diff
(97.9 %id)
BE827158 lung_tumor .a 1717 to 2101 387 to 2       386/387
(99 %)
0 diff
(100 %id)
BE837230 prostate_normal .a 1719 to 2094 1 to 372       372/372
(100 %)
5 diff
(98.7 %id)
BE774080 prostate_tumor .a 1724 to 2112 1 to 388       388/395
(98 %)
17 diff
(95.7 %id)
BE771503 prostate_tumor .a 1743 to 2110 374 to 8       367/374
(98 %)
0 diff
(100 %id)
BG290112 bladder, transitional cell papilloma, cell line .a 1759 to 2461 1 to 703       703/703
(100 %)
6 diff
(99.2 %id)
BE837165 prostate_normal .a 1768 to 2112 1 to 345       345/349
(98 %)
9 diff
(97.5 %id)
BQ372726 prostate_tumor .a 1784 to 2110 342 to 11       332/342
(97 %)
0 diff
(100 %id)
BE771567 prostate_tumor .a 1800 to 2110 330 to 18       313/330
(94 %)
0 diff
(100 %id)
BF000931 breast, lobullar carcinoma in situ .a 1894 to 2193 21 to 323     Submitted on the opposite strand 303/323
(93 %)
6 diff
(98.2 %id)
T74639 Liver .a 1914 to 2245 1 to 336       336/338
(99 %)
9 diff
(97.4 %id)
BG272315 nasopharynx, normal epithelium .a 1921 to 2119 7 to 205       199/215
(92 %)
2 diff
(99.1 %id)
BF242331 bone marrow, from acute myelogenous leukemia .a 1925 to 2486 1 to 559       559/832
(67 %)
21 diff
(97.5 %id)
BQ952101 sciatic nerve .a 1936 to 2447 1 to 520       520/1087
(47 %)
38 diff
(96.6 %id)
BE868468 adenocarcinoma, colon .a 1958 to 2770 1 to 809       809/865
(93 %)
43 diff
(95.1 %id)
CF139320 CNCAP(3)T-225 cell line, Prostate .a 1974 to 2513 1 to 540       540/540
(100 %)
6 diff
(98.9 %id)
TI_154169526   .a 1981 to 2724 90 to 842       753/987
(76 %)
23 diff
(97.7 %id)
CF138795 CNCAP(3)T-225 cell line, Prostate .a 2000 to 2469 8 to 477       470/477
(98 %)
6 diff
(98.8 %id)
TI_154168905   .a 2000 to 2504 80 to 584       505/505
(100 %)
0 diff
(100 %id)
EC446084 Prostate .a 2023 to 2125 102 to 1       102/122
(83 %)
1 diff
(99.2 %id)
FN096111 breast carcinoma .a 2038 to 2126 1 to 89       89/89
(100 %)
3 diff
(96.7 %id)
EC442269 Prostate .a 2047 to 2165 120 to 1       120/120
(100 %)
4 diff
(96.7 %id)
AW449787   .b-u 1 to 447 447 to 1   tiling clone,   447/447
(100 %)
2 diff
(99.6 %id)
EC476538 Prostate .b-u 255 to 366 112 to 1       112/112
(100 %)
1 diff
(99.2 %id)
EC519657 Prostate .b-u 255 to 359 115 to 11       105/115
(91 %)
0 diff
(100 %id)
EC523908 Prostate .b-u 255 to 365 111 to 1       111/111
(100 %)
1 diff
(99.1 %id)
EC504768 Prostate .b-u 260 to 365 105 to 1       105/110
(95 %)
1 diff
(99.1 %id)
BF062922 colon, colon tumor, RER+ .b-u 441 to 1046 1 to 606   tiling clone, Submitted on the opposite strand 606/606
(100 %)
2 diff
(99.7 %id)
AW135607   .b-u 442 to 862 1 to 421     Submitted on the opposite strand 421/421
(100 %)
0 diff
(100 %id)
BE736551 adenocarcinoma, Pancreas .b-u 473 to 1044 1 to 592       592/1320
(44 %)
14 diff
(99.0 %id)
BI819070 pooled brain, lung, testis .b-u 591 to 1407 1 to 821       821/822
(99 %)
15 diff
(98.2 %id)
TI_57196692   .b-u 591 to 1407 72 to 892       821/893
(91 %)
15 diff
(98.4 %id)
BE094291 breast .b-u 610 to 840 27 to 258       232/258
(89 %)
6 diff
(97.7 %id)
TI_1948132883   .b-u 708 to 1468 893 to 125   tiling clone,   769/1282
(59 %)
0 diff
(100 %id)
TI_1948132572   .b-u 759 to 1468 845 to 123       723/1268
(57 %)
0 diff
(100 %id)
TI_1948131936   .b-u 783 to 1468 817 to 122       696/1321
(52 %)
0 diff
(100 %id)
BG287419 bladder, transitional cell papilloma, cell line .b-u 821 to 913 1 to 94       94/94
(100 %)
5 diff
(94.7 %id)
EC464829 Prostate .b-u 831 to 946 1 to 111       111/111
(100 %)
7 diff
(93.7 %id)
EC521296 Prostate .b-u 876 to 998 1 to 119       119/119
(100 %)
10 diff
(91.6 %id)
EC449326 Prostate .b-u 1019 to 1139 1 to 119       119/119
(100 %)
2 diff
(98.4 %id)
BF063083 colon, colon tumor, RER+ .b-u 1062 to 1573 1 to 512     Submitted on the opposite strand 512/512
(100 %)
2 diff
(99.7 %id)
CN284155 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .b-u 1081 to 1467 1 to 387       387/387
(100 %)
4 diff
(99.0 %id)
EC562958 Prostate .b-u 1120 to 1232 1 to 111       111/115
(96 %)
4 diff
(96.6 %id)
EC493173 Prostate .b-u 1134 to 1253 1 to 120       120/120
(100 %)
0 diff
(100 %id)
EC558396 Prostate .b-u 1140 to 1253 11 to 124       114/124
(91 %)
6 diff
(95.2 %id)
EC540330 Prostate .b-u 1144 to 1253 8 to 116       109/116
(93 %)
6 diff
(94.9 %id)
EC462884 Prostate .b-u 1154 to 1266 1 to 110       110/110
(100 %)
10 diff
(91.0 %id)
EC492951 Prostate .b-u 1156 to 1266 1 to 111       111/111
(100 %)
2 diff
(98.2 %id)
EC535380 Prostate .b-u 1156 to 1266 1 to 110       110/110
(100 %)
3 diff
(97.3 %id)
EC477625 Prostate .b-u 1157 to 1266 1 to 110       110/110
(100 %)
0 diff
(100 %id)
EC468850 Prostate .b-u 1198 to 1301 1 to 102       102/102
(100 %)
2 diff
(98.1 %id)
EC571222 Prostate .b-u 1204 to 1306 1 to 103       103/103
(100 %)
0 diff
(100 %id)
EC500050 Prostate .b-u 1205 to 1307 1 to 103       103/104
(99 %)
1 diff
(99.1 %id)
EC553775 Prostate .b-u 1209 to 1310 1 to 101       101/105
(96 %)
5 diff
(95.3 %id)
EC498030 Prostate .b-u 1213 to 1310 1 to 99       99/108
(91 %)
3 diff
(97.3 %id)
EC558229 Prostate .b-u 1216 to 1310 1 to 95       95/104
(91 %)
2 diff
(98.1 %id)
EC451578 Prostate .b-u 1219 to 1310 9 to 99       91/103
(88 %)
3 diff
(97.1 %id)
EC481590 Prostate .b-u 1219 to 1310 11 to 101       91/105
(86 %)
3 diff
(97.2 %id)
EC512287 Prostate .b-u 1225 to 1310 1 to 83       83/92
(90 %)
5 diff
(94.6 %id)
EC446408 Prostate .b-u 1229 to 1310 1 to 82       82/92
(89 %)
2 diff
(97.9 %id)
EC519174 Prostate .b-u 1229 to 1310 1 to 82       82/92
(89 %)
2 diff
(97.9 %id)
EC577253 Prostate .b-u 1229 to 1310 1 to 82       82/92
(89 %)
2 diff
(97.9 %id)
EC472686 Prostate .b-u 1233 to 1310 1 to 78       78/88
(88 %)
2 diff
(97.8 %id)
BE771586 prostate_tumor .b-u 1303 to 1660 1 to 360       360/360
(100 %)
8 diff
(97.8 %id)
BE827176 lung_tumor .b-u 1303 to 1643 1 to 339       339/339
(100 %)
8 diff
(97.7 %id)
BE771470 prostate_tumor .b-u 1310 to 1452 22 to 165       144/165
(87 %)
6 diff
(96.4 %id)
BE771520 prostate_tumor .b-u 1310 to 1658 21 to 373       353/373
(94 %)
6 diff
(98.4 %id)
BE771525 prostate_tumor .b-u 1310 to 1622 10 to 322       313/322
(97 %)
6 diff
(98.2 %id)
BE837311 prostate_normal .b-u 1310 to 1651 442 to 101       342/451
(75 %)
0 diff
(100 %id)
BE837313 prostate_normal .b-u 1310 to 1651 474 to 133   tiling clone,   342/483
(70 %)
0 diff
(100 %id)
BE771472 prostate_tumor .b-u 1311 to 1459 21 to 172       152/176
(86 %)
5 diff
(97.2 %id)
BE771587 prostate_tumor .b-u 1311 to 1644 8 to 344       337/344
(97 %)
6 diff
(98.3 %id)
BE694018 breast .b-u 1313 to 1615 31 to 340       310/340
(91 %)
6 diff
(98.3 %id)
BF358660 lung_tumor .b-u 1314 to 1461 149 to 2       148/149
(99 %)
0 diff
(100 %id)
BE771590 prostate_tumor .b-u 1369 to 1654 353 to 68       286/353
(81 %)
12 diff
(96.7 %id)
BQ372715 prostate_tumor .b-u 1369 to 1589 366 to 146       221/366
(60 %)
0 diff
(100 %id)
BF372873 prostate_tumor .b-u 1377 to 1589 219 to 7       213/219
(97 %)
0 diff
(100 %id)
BF372872 prostate_tumor .b-u 1379 to 1589 216 to 6       211/216
(97 %)
0 diff
(100 %id)
BQ372727 prostate_tumor .b-u 1380 to 1589 351 to 142       210/351
(59 %)
0 diff
(100 %id)
BE771585 prostate_tumor .b-u 1489 to 1669 1 to 180   tiling clone,   180/180
(100 %)
7 diff
(96.2 %id)
EC457739 Prostate .b-u 1503 to 1615 1 to 108       108/108
(100 %)
5 diff
(95.4 %id)
EC471474 Prostate .b-u 1503 to 1615 1 to 108       108/108
(100 %)
5 diff
(95.4 %id)
EC487763 Prostate .b-u 1505 to 1615 1 to 109       109/109
(100 %)
6 diff
(94.5 %id)
AK316360 breast, tumor tissue .c 1 to 1792 1 to 1792 exact tiling clone,   1792/1792
(100 %)
0 diff
(100 %id)
DC393182 breast, tumor tissue .c 1 to 349 1 to 349       349/349
(100 %)
0 diff
(100 %id)
AK304119 trachea .d 1 to 1806 1 to 1806 A50T D125G tiling clone,   1806/1806
(100 %)
2 diff
(99.9 %id)
DC416231 trachea .d 1 to 564 1 to 567       567/567
(100 %)
5 diff
(99.2 %id)
BE769422 prostate_tumor .d 1729 to 1987 273 to 19       255/273
(93 %)
0 diff
(100 %id)
AU119910 whole embryo, mainly head .d 1731 to 2578 2 to 854   tiling clone, capped   853/865
(98 %)
14 diff
(98.4 %id)
AA532907 normal prostatic epithelial cells, Prostate .d 1738 to 2169 3 to 450       448/500
(89 %)
36 diff
(92.8 %id)
FN132233 breast carcinoma .d 1759 to 1870 1 to 107       107/107
(100 %)
7 diff
(93.5 %id)
BM854964 stomach .d 1766 to 2360 1 to 595       595/595
(100 %)
0 diff
(100 %id)
AW949173 prostate_tumor .d 1770 to 2027 1 to 259       259/259
(100 %)
9 diff
(96.6 %id)
BG287384 bladder, transitional cell papilloma, cell line .d 1784 to 2544 1 to 775       775/936
(82 %)
38 diff
(96.0 %id)
CF134672 CNCAP(3)T-225 cell line, Prostate .d 1909 to 2470 8 to 569       562/569
(98 %)
6 diff
(99.0 %id)
TI_154162758   .d 1909 to 2590 81 to 770       690/1365
(50 %)
29 diff
(97.9 %id)
BQ953704 sciatic nerve .d 1930 to 2805 878 to 1     Submitted on the opposite strand 878/878
(100 %)
9 diff
(99.0 %id)
BQ310595 breast .d 1943 to 2582 15 to 655       641/658
(97 %)
32 diff
(95.2 %id)
BQ306691 breast .d 1949 to 2524 582 to 9       574/587
(97 %)
0 diff
(100 %id)
FN117696 breast carcinoma .d 1954 to 2062 1 to 108       108/108
(100 %)
3 diff
(97.3 %id)
FN164124 breast carcinoma .d 1962 to 2070 1 to 109       109/109
(100 %)
0 diff
(100 %id)
BX105480 carcinoid, lung .d 1963 to 2422 1 to 460       460/460
(100 %)
0 diff
(100 %id)
FN131859 breast carcinoma .d 1977 to 2062 1 to 86       86/86
(100 %)
2 diff
(97.7 %id)
FN115080 breast carcinoma .d 1980 to 2073 93 to 1     Submitted on the opposite strand 93/93
(100 %)
1 diff
(99.0 %id)
TI_149315896   .d 1981 to 2911 1005 to 89   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 917/1016
(90 %)
22 diff
(97.9 %id)
BG291838 bladder, transitional cell papilloma, cell line .d 2013 to 2772 1 to 778       778/889
(87 %)
23 diff
(97.5 %id)
FN074305 breast carcinoma .d 2057 to 2143 1 to 87       87/87
(100 %)
0 diff
(100 %id)
BE087458 breast .d 2068 to 2422 3 to 353       351/353
(99 %)
6 diff
(98.4 %id)
BE087567 breast .d 2068 to 2422 3 to 353       351/353
(99 %)
6 diff
(98.4 %id)
FN123733 breast carcinoma .d 2071 to 2140 1 to 68       68/68
(100 %)
5 diff
(92.7 %id)
BF673769 Prostate .d 2073 to 2702 1 to 632       632/843
(74 %)
20 diff
(97.7 %id)
TI_149276647   .d 2115 to 2911 891 to 99   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 793/839
(94 %)
14 diff
(98.4 %id)
FN154003 breast carcinoma .d 2127 to 2200 75 to 1     Submitted on the opposite strand 75/75
(100 %)
1 diff
(98.7 %id)
CA312878 Human Lung Epithelial cells, lung .d 2132 to 2911 796 to 16   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 781/781
(100 %)
1 diff
(99.9 %id)
CB851712 lung, Primary Lung Cystic Fibrosis EpithelialCells .d 2134 to 2911 793 to 16   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 778/778
(100 %)
0 diff
(100 %id)
FN153427 breast carcinoma .d 2144 to 2208 1 to 64       64/64
(100 %)
3 diff
(95.4 %id)
AA177116   .d 2154 to 2464 8 to 334       327/334
(97 %)
6 diff
(98.3 %id)
CR736100 Prostate .d 2160 to 2649 1 to 490       490/490
(100 %)
0 diff
(100 %id)
FN164985 breast carcinoma .d 2162 to 2253 94 to 1     Submitted on the opposite strand 94/94
(100 %)
4 diff
(95.8 %id)
BF082708 breast .d 2177 to 2663 1 to 487       487/487
(100 %)
7 diff
(98.6 %id)
BG949622 breast .d 2177 to 2663 1 to 487       487/487
(100 %)
7 diff
(98.6 %id)
BU608051 Human Lung Epithelial cells, lung .d 2203 to 2911 724 to 16   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 709/709
(100 %)
0 diff
(100 %id)
FN102029 breast carcinoma .d 2224 to 2330 1 to 109       109/109
(100 %)
2 diff
(98.2 %id)
FN080362 breast carcinoma .d 2243 to 2308 1 to 64       64/64
(100 %)
2 diff
(96.9 %id)
FN118826 breast carcinoma .d 2244 to 2330 1 to 88       88/88
(100 %)
3 diff
(96.6 %id)
FN112374 breast carcinoma .d 2247 to 2356 1 to 107       107/107
(100 %)
5 diff
(95.4 %id)
FN119509 breast carcinoma .d 2254 to 2337 1 to 80       80/80
(100 %)
6 diff
(92.5 %id)
FN148850 breast carcinoma .d 2258 to 2365 108 to 1     Submitted on the opposite strand 108/108
(100 %)
0 diff
(100 %id)
BG986598 head_neck .d 2263 to 2614 348 to 2       347/348
(99 %)
0 diff
(100 %id)
BP292262 lung .d 2267 to 2852 1 to 586       586/586
(100 %)
0 diff
(100 %id)
BU677322 lung, Primary Lung Epithelial Cells .d 2310 to 2911 616 to 16   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 601/601
(100 %)
1 diff
(99.9 %id)
BF000514 colon, colon tumor, RER+ .d 2319 to 2915 597 to 1   tiling clone,   597/597
(100 %)
0 diff
(100 %id)
AW195705 Kidney .d 2322 to 2911 590 to 1       590/590
(100 %)
2 diff
(99.7 %id)
AW750756 colon_normal .d 2346 to 2485 1 to 141       141/141
(100 %)
7 diff
(95.1 %id)
EC480622 Prostate .d 2349 to 2438 90 to 1       90/90
(100 %)
0 diff
(100 %id)
AI811008 Prostate .d 2350 to 2911 562 to 1       562/562
(100 %)
1 diff
(99.9 %id)
BF448367 carcinoid, lung .d 2352 to 2914 563 to 1       563/563
(100 %)
0 diff
(100 %id)
FN083239 breast carcinoma .d 2358 to 2450 1 to 94       94/96
(97 %)
2 diff
(98.0 %id)
AI694151 carcinoid, lung .d 2361 to 2910 550 to 1       550/550
(100 %)
0 diff
(100 %id)
BF195266 carcinoid, lung .d 2361 to 2915 555 to 1       555/555
(100 %)
0 diff
(100 %id)
BE769353 prostate_tumor .d 2370 to 2664 310 to 17       294/323
(91 %)
0 diff
(100 %id)
CV368767 prostate_tumor .d 2379 to 2640 264 to 1     Submitted on the opposite strand 264/297
(88 %)
17 diff
(94.3 %id)
FN122656 breast carcinoma .d 2385 to 2477 92 to 1     Submitted on the opposite strand 92/93
(98 %)
1 diff
(99.0 %id)
BE348594 carcinoid, lung .d 2386 to 2910 525 to 1       525/525
(100 %)
0 diff
(100 %id)
FN145381 breast carcinoma .d 2388 to 2482 1 to 94       94/98
(95 %)
4 diff
(96.0 %id)
FN172481 breast carcinoma .d 2403 to 2506 101 to 1     Submitted on the opposite strand 101/103
(98 %)
2 diff
(98.1 %id)
BF509600   .d 2437 to 2915 490 to 14       477/490
(97 %)
0 diff
(100 %id)
AI347950 adenocarcinoma, colon .d 2445 to 2911 477 to 11   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 467/467
(100 %)
0 diff
(100 %id)
AI201455 Prostate .d 2449 to 2911 464 to 1       464/466
(99 %)
3 diff
(99.4 %id)
CA311690 Human Lung Epithelial cells, lung .d 2455 to 2911 472 to 16   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 457/457
(100 %)
1 diff
(99.8 %id)
EC449969 Prostate .d 2465 to 2590 1 to 123       123/123
(100 %)
6 diff
(95.2 %id)
EC473040 Prostate .d 2465 to 2580 1 to 114       114/120
(95 %)
8 diff
(93.4 %id)
EC531925 Prostate .d 2466 to 2587 1 to 118       118/120
(98 %)
7 diff
(94.2 %id)
EC531676 Prostate .d 2467 to 2590 1 to 120       120/120
(100 %)
4 diff
(96.7 %id)
AI073898 breast .d 2471 to 2915 445 to 1       445/445
(100 %)
0 diff
(100 %id)
AA652680   .d 2474 to 2911 457 to 20   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 438/438
(100 %)
6 diff
(98.7 %id)
EC459064 Prostate .d 2479 to 2596 1 to 126       126/126
(100 %)
8 diff
(93.7 %id)
EC464997 Prostate .d 2480 to 2595 1 to 113       113/115
(98 %)
8 diff
(93.1 %id)
BE769372 prostate_tumor .d 2485 to 2664 198 to 19       180/198
(90 %)
0 diff
(100 %id)
AA613671 Prostate, prostate tumor .d 2495 to 2913 419 to 1       419/419
(100 %)
0 diff
(100 %id)
AI318364 adenocarcinoma, colon .d 2504 to 2914 411 to 1       411/411
(100 %)
0 diff
(100 %id)
FN153899 breast carcinoma .d 2508 to 2587 1 to 80       80/82
(97 %)
2 diff
(97.6 %id)
BF154779 breast .d 2509 to 2738 34 to 260       227/270
(84 %)
4 diff
(98.6 %id)
BF449044 Prostate .d 2510 to 2916 407 to 1       407/407
(100 %)
0 diff
(100 %id)
CB129519 Liver .d 2511 to 2877 1 to 367       367/367
(100 %)
1 diff
(99.8 %id)
EC550646 Prostate .d 2512 to 2615 1 to 103       103/103
(100 %)
1 diff
(99.1 %id)
AA507550 Prostate .d 2529 to 2911 1 to 383   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 383/383
(100 %)
8 diff
(98.0 %id)
FN124472 breast carcinoma .d 2534 to 2606 72 to 1     Submitted on the opposite strand 72/75
(96 %)
1 diff
(98.7 %id)
AW971075   .d 2536 to 2911 111 to 486   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 376/486
(77 %)
6 diff
(98.8 %id)
AA693692 liver and spleen .d 2537 to 2908 372 to 1       372/372
(100 %)
0 diff
(100 %id)
FN171714 breast carcinoma .d 2544 to 2640 92 to 1     Submitted on the opposite strand 92/95
(96 %)
9 diff
(90.6 %id)
FN084324 breast carcinoma .d 2547 to 2646 101 to 1     Submitted on the opposite strand 101/101
(100 %)
1 diff
(99.1 %id)
TI_149289618   .d 2560 to 3345 864 to 84   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 781/961
(81 %)
10 diff
(99.0 %id)
FN114554 breast carcinoma .d 2578 to 2675 98 to 1     Submitted on the opposite strand 98/98
(100 %)
4 diff
(96.0 %id)
AI032599 liver and spleen .d 2581 to 2911 331 to 1       331/331
(100 %)
1 diff
(99.7 %id)
FN084560 breast carcinoma .d 2587 to 2640 1 to 54       54/55
(98 %)
1 diff
(98.2 %id)
BF590824 colon, colon tumor, RER+ .d 2599 to 3118 527 to 6       522/527
(99 %)
0 diff
(100 %id)
AA991871 germ cell tumor .d 2614 to 2911 298 to 1       298/298
(100 %)
0 diff
(100 %id)
EC560358 Prostate .d 2617 to 2716 1 to 100       100/100
(100 %)
0 diff
(100 %id)
EC530237 Prostate .d 2629 to 2728 1 to 99       99/107
(92 %)
2 diff
(98.2 %id)
EC486885 Prostate .d 2630 to 2738 1 to 109       109/109
(100 %)
2 diff
(98.2 %id)
BM970983 lung .d 2631 to 3345 735 to 19   tiling clone, AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 717/717
(100 %)
3 diff
(99.6 %id)
FN055356 breast carcinoma .d 2642 to 2748 107 to 1     Submitted on the opposite strand 107/107
(100 %)
1 diff
(99.1 %id)
AI380832 B-cell, chronic lymphotic leukemia .d 2644 to 3106 463 to 1       463/463
(100 %)
0 diff
(100 %id)
FN102474 breast carcinoma .d 2656 to 2744 1 to 86       86/87
(98 %)
4 diff
(95.5 %id)
BG288289 bladder, transitional cell papilloma, cell line .d 2661 to 2911 1 to 249   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 249/249
(100 %)
3 diff
(98.8 %id)
EC439956 Prostate .d 2675 to 2788 1 to 111       111/114
(97 %)
4 diff
(96.5 %id)
BU540218 mixed (pool of 40 RNAs) .d 2688 to 2911 1 to 224       224/344
(65 %)
2 diff
(99.5 %id)
AI269801 adenocarcinoma, colon .d 2712 to 2914 203 to 1       203/203
(100 %)
0 diff
(100 %id)
EC515277 Prostate .d 2791 to 2910 120 to 3       118/120
(98 %)
0 diff
(100 %id)
FN062612 breast carcinoma .d 2793 to 2904 112 to 1     Submitted on the opposite strand 112/113
(99 %)
0 diff
(100 %id)
EC462626 Prostate .d 2810 to 2910 1 to 97       97/101
(96 %)
5 diff
(95.1 %id)
FN071480 breast carcinoma .d 2828 to 2910 1 to 84       84/87
(96 %)
2 diff
(97.8 %id)
AW993522 breast_normal .d 3066 to 3693 626 to 3   tiling clone, Submitted on the opposite strand 624/626
(99 %)
0 diff
(100 %id)
AI732525 Prostate .d 3163 to 3452 299 to 10   AAA   290/306
(94 %)
0 diff
(100 %id)
AI791480 Prostate .d 3163 to 3452 7 to 296       290/311
(93 %)
1 diff
(99.7 %id)
AA506311 Prostate .d 3163 to 3452 298 to 8   AAA   291/305
(95 %)
0 diff
(100 %id)
AA507242 Prostate .d 3163 to 3444 301 to 19       283/307
(92 %)
0 diff
(100 %id)
AW016378   .d 3163 to 3561 1 to 398     Submitted on the opposite strand 398/398
(100 %)
1 diff
(99.8 %id)
BX089258 Prostate .d 3166 to 3432 1 to 267       267/267
(100 %)
0 diff
(100 %id)
CR740089 adenocarcinoma, Pancreas .d 3166 to 3438 1 to 273       273/273
(100 %)
0 diff
(100 %id)
CR740133 metastatic prostate bone lesion .d 3166 to 3452 1 to 287       287/306
(93 %)
1 diff
(99.7 %id)
AW993690 breast_normal .d 3167 to 3685 524 to 8   tiling clone, AAA Submitted on the opposite strand 517/605
(85 %)
0 diff
(100 %id)
AA687191   .d 3168 to 3502 342 to 8   AAA   335/349
(95 %)
0 diff
(100 %id)
AI821254   .d 3168 to 3502 33 to 367       335/382
(87 %)
1 diff
(99.8 %id)
AI821905   .d 3168 to 3502 368 to 34   AAA   335/375
(89 %)
0 diff
(100 %id)
AW971373   .d 3174 to 3452 363 to 85     Submitted on the opposite strand 279/363
(76 %)
0 diff
(100 %id)
AA503957 Prostate .d 3177 to 3452 283 to 8       276/283
(97 %)
0 diff
(100 %id)
AI791299 Prostate .d 3179 to 3452 1 to 275       275/289
(95 %)
3 diff
(99.0 %id)
BF447032 Prostate .d 3180 to 3437 1 to 258     Submitted on the opposite strand 258/258
(100 %)
0 diff
(100 %id)
BX110546 normal prostate, Prostate .e 1 to 789 1 to 789 exact tiling clone,   789/789
(100 %)
3 diff
(99.7 %id)
BU963269 mixed (pool of 40 RNAs) .e 333 to 814 1 to 482       482/483
(99 %)
3 diff
(99.4 %id)
AA541708 normal prostate, Prostate .e 416 to 813 400 to 1       498/568
(87 %)
23 diff
(96.0 %id)
AI693336 carcinoid, lung .e 605 to 1149 554 to 10       545/554
(98 %)
0 diff
(100 %id)
AI702953 carcinoid, lung .e 605 to 1149 554 to 10       545/554
(98 %)
0 diff
(100 %id)
BE467167 carcinoid, lung .e 619 to 1158 542 to 1       542/542
(100 %)
2 diff
(99.7 %id)
BE550961 carcinoid, lung .e 640 to 1158 519 to 1       519/519
(100 %)
2 diff
(99.7 %id)
BE222309 carcinoid, lung .e 689 to 1158 470 to 1   tiling clone,   470/470
(100 %)
0 diff
(100 %id)
AI299348 carcinoid, lung .e 722 to 1158 437 to 1       437/437
(100 %)
0 diff
(100 %id)
FN087307 breast carcinoma .e 873 to 965 1 to 94       94/95
(98 %)
3 diff
(96.9 %id)
AW292425   .e 921 to 1159 255 to 17   AAA Possibly primed on the genome, locally A rich (12/12 A in genome downstream of last aligned base) 239/239
(100 %)
16 diff
(93.4 %id)
FN061897 breast carcinoma .e 1094 to 1154 61 to 1     Submitted on the opposite strand 61/64
(95 %)
0 diff
(100 %id)
CV340915 prostate_tumor .e 1135 to 1271 1 to 138   tiling clone,   138/140
(98 %)
11 diff
(92.2 %id)
CV340937 prostate_tumor .e 1138 to 1305 164 to 1   tiling clone, Submitted on the opposite strand 164/167
(98 %)
9 diff
(94.7 %id)
BE670418 carcinoid, lung .f-u 1 to 445 445 to 1       445/445
(100 %)
0 diff
(100 %id)
BF447818 carcinoid, lung .f-u 1 to 484 485 to 2   tiling clone,   484/485
(99 %)
0 diff
(100 %id)
DB008460 cervix, tumor tissue .f-u 304 to 849 2 to 556   to resequence, capped   555/555
(100 %)
11 diff
(98.1 %id)
BE218603 carcinoid, lung .f-u 477 to 844 1 to 368     Submitted on the opposite strand 368/368
(100 %)
1 diff
(99.8 %id)
AW295342   .f-u 478 to 919 1 to 442   tiling clone, Submitted on the opposite strand 442/451
(98 %)
1 diff
(99.8 %id)
BE550975 carcinoid, lung .f-u 479 to 844 1 to 366     Submitted on the opposite strand 366/366
(100 %)
0 diff
(100 %id)
BE502739 carcinoid, lung .f-u 547 to 885 1 to 340     Submitted on the opposite strand 340/340
(100 %)
5 diff
(98.6 %id)
AI525821 Prostate .f-u 1254 to 1930 86 to 779 exact tiling clone,   694/785
(88 %)
58 diff
(92.7 %id)
FN166359 breast carcinoma .f-u 1418 to 1520 1 to 102       102/102
(100 %)
4 diff
(96.1 %id)
FN052196 breast carcinoma .f-u 1468 to 1537 1 to 70       70/71
(98 %)
1 diff
(98.6 %id)
BF511786   .f-u 1477 to 1735 274 to 16   tiling clone, AAA   259/259
(100 %)
1 diff
(99.7 %id)
DB335295 cervix, tumor tissue .f-u 1538 to 2094 556 to 1   tiling clone, to resequence,   556/556
(100 %)
1 diff
(99.9 %id)
FN106919 breast carcinoma .f-u 1574 to 1656 81 to 1     Submitted on the opposite strand 81/81
(100 %)
2 diff
(97.6 %id)
FN093577 breast carcinoma .f-u 1599 to 1673 1 to 71       71/72
(98 %)
9 diff
(87.5 %id)
AW205279   .f-u 1734 to 2111 378 to 1   tiling clone,   378/388
(97 %)
1 diff
(99.8 %id)
DC392947 breast, tumor tissue .g 1 to 507 1 to 508 G28R R29P S31V L32A R33S ... tiling clone,   508/508
(100 %)
1 diff
(99.9 %id)
? Gene Summary Gene on genome mRNA:.a, .b-u, .c, .d, .e, .f-u, .g Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes DCI